Enliven Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Enliven Therapeutics, Inc. has filed 784 SEC EDGAR filings since 21 Apr 2016

SEC filing history

Showing 476-500 of 784 matching filings.

Per page
25
Current page
20
144 File 001-39247

144 filing

Filing date
22 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Dec 2023
Reporting date
19 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Dec 2023
Reporting date
19 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
20 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
19 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Nov 2023
Reporting date
03 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Nov 2023
Reporting date
03 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Sep 2023
Reporting date
26 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Sep 2023
Reporting date
25 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
25 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2023
Reporting date
24 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91465

SC 13D/A

Filing date
28 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
24 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
24 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-272909

424B5

Filing date
06 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-272909

EFFECT filing

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .